1
Return

Morphological heterogeneities in prostate cancer bone metastases are related to molecular subtypes and prognosis

delete2025-08-21
delete0
delete
OA
AI
S
Sofia Halin Bergström *
J
Julius Semenas
A
Annika Nordstrand
E
Elin Thysell
J
Johan Wänman
S
Sead Crnalic
A
Anders Widmark
C
Camilla Thellenberg‐Karlsson
P
Pernilla Andersson
S
Susanne Gidlund
M
Marie Lundholm
K
Karin Welén
A
Andreas Josefsson
P
Pernilla Wikström
A
Anders Bergh
DOI:10.1007/s10585-025-10365-ydelete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
We previously identified three molecular subtypes of prostate cancer (PC) bone metastases, MetA-C, with MetB linked to poor prognosis after androgen deprivation therapy (ADT). This study analyzed epithelial and stromal markers using immunohistochemistry, focusing on their relationship to MetA-C subtypes, spatial heterogeneities, and clinical outcomes after ADT. High tumor proliferation and low PSA expression were associated with MetB and poor outcomes after ADT. Most metastases contained tumor epithelial subclones with different morphologies. In the metastasis stroma, blood vessels and fibroblast-like cells expressed smooth muscle actin (SMA), platelet-derived growth factor β, stroma-derived factor 1 (SDF1), periostin (POSTN), and decorin (DCN). Compared to each other, MetB metastases had higher SMA and ERG + endothelial cell densities, while MetA cases showed higher SDF1 and DCN levels. Accordingly, high POSTN and ERG + densities were associated with poor outcomes after ADT, whereas high DCN indicated favorable prognosis. Low levels of AR-positive stromal cells were linked to poor outcomes. Macrophage and T-lymphocyte densities showed no significant associations with metastases subtypes or outcome. Two stroma subtypes were identified: subtype 1 with higher bone content, lower vessel density, MetA-enrichment and better prognosis compared to subtype 2 that exhibited higher tumor proliferation and lower PSA expression. Most metastases contained regions of both stroma subtypes.
Keywords:
Prostate cancer metastases
Bone metastasis stroma
Metastatic stroma
Prostate cancer molecular subtypes
Tumor heterogeneity
Stromal markers
Metastases morphology
Tumor microenvironment
Androgen deprivation therapy
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

C
Clinical and Experimental Metastasis
IF:
3.2
Papers:
2.4K
Citations:
3.4K

Organization

D
Department of Medical Biosciences
Scholars:
92
Papers: 37
Citations: 0
I
Institute of Clinical Sciences
Scholars:
161
Papers: 84
Citations: 0
D
Department of Diagnostics and Interventions
Scholars:
6
Papers: 2
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers